Two studies in mice now show that researchers can control when and where CAR T cells are active, potentially overcoming previous hurdles for CAR T–based treatments.
The Scientist’s Creative Services Team | Nov 7, 2022 | 1 min read
In this webinar, Douglas Green will describe how early events in T cell activation influence anti-tumor immunity.
ADVERTISEMENT
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.